1.035
price up icon1.47%   0.015
after-market アフターアワーズ: 1.04 0.005 +0.48%
loading
前日終値:
$1.02
開ける:
$1.03
24時間の取引高:
45,702
Relative Volume:
0.48
時価総額:
$20.16M
収益:
$411.00K
当期純損益:
$-4.85M
株価収益率:
-2.3523
EPS:
-0.44
ネットキャッシュフロー:
$-4.88M
1週間 パフォーマンス:
+6.70%
1か月 パフォーマンス:
-11.54%
6か月 パフォーマンス:
-50.24%
1年 パフォーマンス:
-72.76%
1日の値動き範囲:
Value
$1.02
$1.05
1週間の範囲:
Value
$0.97
$1.12
52週間の値動き範囲:
Value
$0.9452
$4.44

Lexaria Bioscience Corp Stock (LEXX) Company Profile

Name
名前
Lexaria Bioscience Corp
Name
セクター
Healthcare (1177)
Name
電話
250-765-6424
Name
住所
100 - 740 MCCURDY ROAD, KELOWNA
Name
職員
7
Name
Twitter
Name
次回の収益日
2025-04-28
Name
最新のSEC提出書
Name
LEXX's Discussions on Twitter

LEXX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
LEXX
Lexaria Bioscience Corp
1.035 18.97M 411.00K -4.85M -4.88M -0.44
Biotechnology icon
ONC
Beone Medicines Ltd Adr
246.68 25.81B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
447.09 111.46B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.30 40.37M 0 0 0 0.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
605.39 64.44B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
VRNA
Verona Pharma Plc Adr
77.49 6.19B 0 -153.72M -103.81M -2.00

Lexaria Bioscience Corp (LEXX) 最新ニュース

pulisher
May 27, 2025

Lexaria Bioscience Corp (NASDAQ: LEXX) Is Down -15.79% Since Its Low, And It’s Only Getting Started. - Stocksregister

May 27, 2025
pulisher
May 14, 2025

Lexaria advances drug delivery tech with PharmaCO By Investing.com - Investing.com Nigeria

May 14, 2025
pulisher
May 14, 2025

Raymond James Financial Inc. Makes New Investment in Lexaria Bioscience Corp. (NASDAQ:LEXX) - Defense World

May 14, 2025
pulisher
May 12, 2025

Lexaria (LEXX) Advances Collaborative Pharmaceutical Research | - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Lexaria Advances Collaboration with Pharma Partner on Drug Delivery Technology - TipRanks

May 12, 2025
pulisher
May 12, 2025

Lexaria Provides Update on Material Transfer Agreement with Pharmaceutical Company - marketscreener.com

May 12, 2025
pulisher
May 12, 2025

Lexaria Provides Update on Material Transfer Agreement with Phar - GuruFocus

May 12, 2025
pulisher
May 03, 2025

Geode Capital Management LLC Increases Position in Lexaria Bioscience Corp. (NASDAQ:LEXX) - Defense World

May 03, 2025
pulisher
May 01, 2025

Lexaria Bioscience announces $2M registered direct offering; shares slip 19% - MSN

May 01, 2025
pulisher
Apr 30, 2025

Lexaria Bioscience stock hits 52-week low at $1.14 By Investing.com - Investing.com India

Apr 30, 2025
pulisher
Apr 30, 2025

Lexaria Bioscience stock hits 52-week low at $1.14 - Investing.com Australia

Apr 30, 2025
pulisher
Apr 28, 2025

Lexaria Announces Closing of $2 Million Registered Direct Offeri - GuruFocus

Apr 28, 2025
pulisher
Apr 28, 2025

Lexaria Announces Closing of $2 Million Registered Direct Offering of Common Stock - Yahoo Finance

Apr 28, 2025
pulisher
Apr 28, 2025

Lexaria Bioscience Secures $2 Million in Direct Stock Offering - TipRanks

Apr 28, 2025
pulisher
Apr 28, 2025

Lexaria Secures $2M Strategic Investment in Clean Direct Offering Amid Market Turbulence - Stock Titan

Apr 28, 2025
pulisher
Apr 28, 2025

Market Watch Highlights: Lexaria Bioscience Corp (LEXX) Ends on an Downturn Note at 1.35 - DWinneX

Apr 28, 2025
pulisher
Apr 28, 2025

Lexaria Bioscience Corp (LEXX) Stock: Navigating Market Highs and Lows in 52 Weeks - investchronicle.com

Apr 28, 2025
pulisher
Apr 28, 2025

What is Zacks Small Cap’s Estimate for LEXX FY2025 Earnings? - Defense World

Apr 28, 2025
pulisher
Apr 25, 2025

Lexaria Bioscience (LEXX) Announces $2M Direct Offering | LEXX S - GuruFocus

Apr 25, 2025
pulisher
Apr 25, 2025

Lexaria Bioscience Secures $2 Million in Registered Direct Stock Offering - citybuzz -

Apr 25, 2025
pulisher
Apr 25, 2025

Lexaria Announces $2 Million Registered Direct Offering of Commo - GuruFocus

Apr 25, 2025
pulisher
Apr 25, 2025

Lexaria Bioscience secures $2 million in direct offering By Investing.com - Investing.com South Africa

Apr 25, 2025
pulisher
Apr 25, 2025

Lexaria Bioscience secures $2 million in direct offering - Investing.com

Apr 25, 2025
pulisher
Apr 25, 2025

Lexaria Announces $2 Million Registered Direct Offering of Common Stock - TradingView

Apr 25, 2025
pulisher
Apr 25, 2025

Lexaria Lands $2M Strategic Investment: Institutional Investor Backs Biotech at $1.00 Per Share - Stock Titan

Apr 25, 2025
pulisher
Apr 25, 2025

Lexaria Bioscience (OTCMKTS:LXRP) versus U.S. Gold (NASDAQ:USAU) Critical Comparison - Defense World

Apr 25, 2025
pulisher
Apr 24, 2025

LEXX: Second Quarter Results - Yahoo Finance

Apr 24, 2025
pulisher
Apr 23, 2025

Lexaria Bioscience (LEXX) Advances in GLP-1 Technology Amid Indu - GuruFocus

Apr 23, 2025
pulisher
Apr 23, 2025

Recent GLP-1-Industry Developments Highlight the Promise of Lexa - GuruFocus

Apr 23, 2025
pulisher
Apr 23, 2025

Recent GLP-1-Industry Developments Highlight the Promise of Lexaria Bioscience's Technology | LEXX Stock News - GuruFocus

Apr 23, 2025
pulisher
Apr 23, 2025

Recent GLP-1-Industry Developments Highlight the Promise of Lexaria Bioscience's Technology - TradingView

Apr 23, 2025
pulisher
Apr 23, 2025

Revolutionary Technology Could Solve GLP-1's Biggest Challenge: 64% Patient Dropout Rate - Stock Titan

Apr 23, 2025
pulisher
Apr 22, 2025

Lexaria Bioscience earnings beat by $0.02, revenue topped estimates - Investing.com

Apr 22, 2025
pulisher
Apr 19, 2025

Lexaria Corp. Announces Oil Discovery at PPF-12-7 well in Belmont Lake - marketscreener.com

Apr 19, 2025
pulisher
Apr 16, 2025

Lifezone Metals (NYSE:LZM) vs. Lexaria Bioscience (OTCMKTS:LXRP) Financial Review - Defense World

Apr 16, 2025
pulisher
Apr 14, 2025

Lexaria Bioscience Corp reports results for the quarter ended February 28Earnings Summary - TradingView

Apr 14, 2025
pulisher
Apr 14, 2025

Lexaria Bioscience Corp. SEC 10-Q Report - TradingView

Apr 14, 2025
pulisher
Apr 13, 2025

60,640 Shares in Lexaria Bioscience Corp. (NASDAQ:LEXX) Acquired by Raymond James Financial Inc. - Defense World

Apr 13, 2025
pulisher
Apr 07, 2025

Lexaria gets ethics board okay for oral GLP-1 study - MSN

Apr 07, 2025
pulisher
Apr 05, 2025

We Think Lexaria Bioscience (NASDAQ:LEXX) Needs To Drive Business Growth Carefully - Yahoo

Apr 05, 2025
pulisher
Apr 05, 2025

HighTower Advisors LLC Boosts Holdings in Lexaria Bioscience Corp. (NASDAQ:LEXX) - Defense World

Apr 05, 2025
pulisher
Apr 03, 2025

Lexaria Completes Enrollment for Pioneering Drug Delivery Study - TipRanks

Apr 03, 2025
pulisher
Apr 03, 2025

Lexaria completes enrollment for diabetes drug study - Investing.com

Apr 03, 2025
pulisher
Apr 03, 2025

Lexaria completes enrollment for diabetes drug study By Investing.com - Investing.com UK

Apr 03, 2025
pulisher
Apr 03, 2025

Lexaria's GLP-1 Study Hits Major Milestone with 20% Higher Patient Enrollment - Stock Titan

Apr 03, 2025
pulisher
Apr 02, 2025

Lexaria begins human trial for oral diabetes treatment - Investing.com India

Apr 02, 2025

Lexaria Bioscience Corp (LEXX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$1.06
price up icon 0.95%
$31.31
price up icon 3.40%
$580.95
price up icon 0.82%
$292.90
price up icon 2.57%
$4.64
price up icon 6.67%
$77.49
price up icon 4.82%
大文字化:     |  ボリューム (24 時間):